Cargando…
Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1
SIMPLE SUMMARY: Immunotherapy is increasingly becoming a success strategy for oncology treatment. Indoleamine-2,3-dioxygenase1 (IDO1) is a tryptophan-degrading enzyme involved in immunological escape mechanisms, which is considered as a potential target for tumor therapy. However, the clinical effic...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496999/ https://www.ncbi.nlm.nih.gov/pubmed/36139584 http://dx.doi.org/10.3390/cancers14184424 |